PP_1170x120_10-25-21

FDA okays Pfizer COVID-19 vaccine for kids 5-11

Print Friendly, PDF & Email

WASHINGTON — The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer’s COVID-19 vaccine.

The FDA cleared kid-size doses — just a third of the amount given to teens and adults — for emergency use, and up to 28 million more American children could be eligible for vaccinations as early as next week.

“As a mother and a physician, I know that parents, caregivers, school staff, and children have been waiting for today’s authorization. Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy,” Acting FDA Commissioner Janet Woodcock said in a statement Friday afternoon.

The process now heads to the Centers for Disease Control and Prevention. An advisory committee for the CDC will meet on Tuesday to discuss the pediatric vaccine safety and efficacy data, as an advisory FDA panel did this past week, and then CDC Director Rochelle Walensky is expected to give the final signoff soon afterward.


EMC_728x90

ECRM_728x90_05-03-22

Comments are closed.